TELA Bio, Inc. (NASDAQ:TELA – Get Rating) insider Ew Healthcare Partners Fund 2, acquired 5,000 shares of TELA Bio stock in a transaction that occurred on Monday, May 23rd. The shares were purchased at an average cost of $8.53 per share, for a total transaction of $42,650.00. Following the purchase, the insider now directly owns […]
TELA Bio, Inc. (NASDAQ:TELA – Get Rating) insider Ew Healthcare Partners Fund 2, bought 5,000 shares of the stock in a transaction on Friday, May 20th. The shares were acquired at an average cost of $8.79 per share, with a total value of $43,950.00. Following the purchase, the insider now owns 3,430,709 shares of the […]
TELA Bio (NASDAQ:TELA – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Tuesday, Zacks.com reports. According to Zacks, “TELA Bio Inc. is a commercial stage medical technology company. It is focused on the designing, developing and marketing of tissue reinforcement materials […]
TELA Bio, Inc. (NASDAQ:TELA – Get Rating) insider Ew Healthcare Partners Fund 2, bought 5,000 shares of the stock in a transaction on Wednesday, May 18th. The shares were bought at an average price of $8.96 per share, for a total transaction of $44,800.00. Following the acquisition, the insider now owns 3,420,709 shares in the […]
Abiomed (NASDAQ:ABMD – Get Rating) and TELA Bio (NASDAQ:TELA – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations. Risk & Volatility Abiomed has a beta of 1.34, suggesting that […]